--- title: "Credit Downgrade Risk Threatens Brown-Forman Inc. A’s Financing Costs and Liquidity" type: "News" locale: "en" url: "https://longbridge.com/en/news/289680899.md" description: "Brown-Forman Inc. (BF.A) faces credit downgrade risks that could significantly increase borrowing costs and restrict access to capital markets, potentially harming liquidity and financial condition. This follows a potential downgrade review in November 2025. The stock's average price target is $26.00, indicating a -5.11% downside potential." datetime: "2026-06-14T06:00:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289680899.md) - [en](https://longbridge.com/en/news/289680899.md) - [zh-HK](https://longbridge.com/zh-HK/news/289680899.md) generator: "portal-rs" --- # Credit Downgrade Risk Threatens Brown-Forman Inc. A’s Financing Costs and Liquidity Brown Forman Inc A (BF.A) has disclosed a new risk, in the Debt & Financing category. ### Introducing TipRanks MCP for Agents - Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. - Designed for personal research, portfolio monitoring, and AI-assisted investment workflows. Brown Forman Inc A faces the risk that a downgrade, or even a review for potential downgrade as seen in November 2025, could materially raise its borrowing costs and constrain its access to commercial paper and other capital markets. Such a shift in credit standing would likely force the company to rely on more expensive financing, pressuring liquidity and weakening its overall financial condition. The average BF.A stock price target is $26.00, implying -5.11% downside potential. To learn more about Brown Forman Inc A’s risk factors, click here. ### Related Stocks - [BF.A.US](https://longbridge.com/en/quote/BF.A.US.md) - [BF.B.US](https://longbridge.com/en/quote/BF.B.US.md) ## Related News & Research - [Flex Announces New Company Name for the Planned Cloud and Power Infrastructure Spin-Off and Files Form 10 Registration Statement | AXM Stock News](https://longbridge.com/en/news/299032012.md) - [BioMarin files Form 3 for director Robert M. Plenge, reporting no beneficial ownership](https://longbridge.com/en/news/298968664.md) - [Morgan Stanley cuts Teleperformance stake to 4.88%](https://longbridge.com/en/news/298933151.md) - [Morgan Stanley lifts Teleperformance stake to 5.12% of capital](https://longbridge.com/en/news/298616558.md) - [Fitch affirms NOS long-term credit rating at BBB, outlook stable](https://longbridge.com/en/news/298751986.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**